Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$354M |
| 2 |
T-Mobile US
TMUS
|
+$282M |
| 3 |
Newell Brands
NWL
|
+$253M |
| 4 |
FedEx
FDX
|
+$166M |
| 5 |
Cardinal Health
CAH
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$214M |
| 2 |
Elevance Health
ELV
|
+$182M |
| 3 |
DXC Technology
DXC
|
+$168M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$154M |
| 5 |
Visa
V
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.35% |
| 2 | Materials | 10.18% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.91% |
| 5 | Consumer Discretionary | 7.22% |
Similar funds
Glenview Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Glenview Capital Management held 64 positions worth $17.1B, down 7.6% from $18.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Glenview Capital Management withdrew a net $607M in Q1 2018, closing 10 positions and reducing 29 holdings. Its most notable exit was Apple, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 44% a quarter earlier, followed by Materials and Communication Services.
Against the trend, Glenview Capital Management opened a new position in Express Scripts Holding Company worth $321M.
- Glenview Capital Management's largest Q1 2018 buy was Express Scripts Holding Company: 4,641,986 shares worth $321M.
- Glenview Capital Management added most to Newell Brands in Q1 2018, an estimated $253M increase.
- Glenview Capital Management's biggest Q1 2018 reduction was Elevance Health, cutting an estimated $182M.
- Glenview Capital Management fully exited Apple in Q1 2018, selling an estimated $214M.
- Glenview Capital Management's ten largest holdings make up 43% of its $17.1B portfolio in Q1 2018.
- Glenview Capital Management opened 6 new positions and closed 10 in Q1 2018.
- Glenview Capital Management's portfolio value fell 7.6% quarter-over-quarter to $17.1B.
Based on Glenview Capital Management's 13F filing for Q1 2018, filed 15 May 2018.